Assessing Psoriasis Treatment Outcomes: a Single-center, Prospective Study Evaluating Patient Outcomes in Psoriasis
Wake Forest University Health Sciences
Summary
To assess the feasibility of AIGPP video interactions with psoriasis patients. To explore patient attitudes, trust, and comfort levels concerning AIGPP interactions in a healthcare setting, and to understand their influence on the patient-physician dynamic. To evaluate medication adherence over a 4-week period in patients with psoriasis randomized to weekly AI-generated automated physician providers (AIGPP) video interactions, weekly human video calls, or standard care (single follow up visit after 4 weeks). Adherence rates will be evaluated via a cap designed to record adherence attached to the study medication container.
Description
Psoriasis is a chronic disease that can negatively impact quality of life. However, adherence to topical treatment for psoriasis can be abysmal. Nonadherence can result in multiple negative effects, including treatment failure, increased healthcare costs, and decreased quality of life. Office visits can drive compliance behavior. By using "white coat compliance," providers increase adherence in the short period before and after a doctor appointment. However, frequent visits may not be feasible for time-constrained healthcare providers. Artificial intelligence (AI) has alleviated provider burde…
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Patients ≥18 years of age * Patients with a current diagnosis of psoriasis suitable for treatment with topical Betamethasone (BD) * Patients who live in the United States * Patients with a sufficient command of the English language * Patients with a mobile device able to at least operate at 25 frames per second (FPS). Exclusion Criteria: * Patients less than the age of 18 * Patients with severe or unstable comorbid conditions * Patient who are pregnant or breastfeeding * Patients with any other skin conditions that prohibit or confound the ability of the investigator t…
Interventions
- BehavioralArtificial intelligence
patients will receive BD and have a weekly virtual visit with an AIGPP
- BehavioralHuman
patients will receive BD and receive weekly video calls from study staff
- OtherStandard of Care
patients will receive BD and scheduled for a single follow up visit in 4 weeks
Location
- Wake Forest University Health Sciences Department of DermatologyWinston-Salem, North Carolina